Yongping Lin

InstitutionThe first affiliated hospital of Guangzhou medical university
AddressGuangdong
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 7 Covid-19 publications, with a maximum of 2 publications in July 2020 and Spetember 2020
    All Publications
    Bar chart showing 38 publications over 15 distinct years, with a maximum of 6 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Chen Q, Yu B, Yang Y, Huang J, Liang Y, Zhou J, Li L, Peng X, Cheng B, Lin Y. Immunological and inflammatory profiles during acute and convalescent phases of severe/ critically ill COVID-19 patients. Int Immunopharmacol. 2021 Aug; 97:107685. PMID: 33951560.
      Citations: 3     Fields:    Translation:HumansCells
    2. Wang W, Liu X, Wu S, Chen S, Li Y, Nong L, Lie P, Huang L, Cheng L, Lin Y, He J. Definition and Risks of Cytokine Release Syndrome in 11 Critically Ill COVID-19 Patients With Pneumonia: Analysis of Disease Characteristics. J Infect Dis. 2020 10 01; 222(9):1444-1451. PMID: 32601708.
      Citations: 48     Fields:    Translation:HumansCellsPHPublic Health
    3. Lu W, Liu X, Wang T, Liu F, Zhu A, Lin Y, Luo J, Ye F, He J, Zhao J, Li Y, Zhong N. Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID-19 patients. J Med Virol. 2021 02; 93(2):582-584. PMID: 32776556.
      Citations: 15     Fields:    Translation:Humans
    4. Xing W, Liu Y, Wang H, Li S, Lin Y, Chen L, Zhao Y, Chao S, Huang X, Ge S, Deng T, Zhao T, Li B, Wang H, Wang L, Song Y, Jin R, He J, Zhao X, Liu P, Li W, Cheng J. A High-Throughput, Multi-Index Isothermal Amplification Platform for Rapid Detection of 19 Types of Common Respiratory Viruses Including SARS-CoV-2. Engineering (Beijing). 2020 Oct; 6(10):1130-1140. PMID: 33520332.
      Citations: 8     
    5. Yang Z, Wu J, Ye F, Zhu B, Guan W, Huang J, Songyang Z, Liu Y, Chen Y, Du Q, Chen J, Zhang Y, Ke C, Lin Y, Sun B, Zeng J, Chen L, Ren J, Jiang X, Yu M, Di B, Zhong N, Zheng L. Expert consensus-based laboratory testing of SARS-CoV-2. J Thorac Dis. 2020 Aug; 12(8):4378-4390. PMID: 32944351.
      Citations: 1     
    6. Bi J, Lin Y, Zhong R, Jiang G, Verma V, Shi H, Li J, Tong X, Li Y, Hu D, Liang W, Han G, He J. Prevalence and clinical characterization of cancer patients with asymptomatic SARS-CoV-2 infection history. J Infect. 2020 12; 81(6):e22-e24. PMID: 32711041.
      Citations: 6     Fields:    Translation:Humans
    7. Liang W, Lin Y, Bi J, Li J, Liang Y, Wong SS, Zanin M, Yang Z, Li C, Zhong R, Jiang G, Han G, Hu D, He J, Zhong N. Serosurvey of SARS-CoV-2 among hospital visitors in China. Cell Res. 2020 09; 30(9):817-818. PMID: 32686766.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    8. Zhao H, Zhou J, Zhang K, Chu H, Liu D, Poon VK, Chan CC, Leung HC, Fai N, Lin YP, Zhang AJ, Jin DY, Yuen KY, Zheng BJ. A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses. Sci Rep. 2016 Feb 25; 6:22008. PMID: 26911565.
      Citations: 54     Fields:    Translation:AnimalsCells
    9. Xu K, Zheng BJ, Zeng R, Lu W, Lin YP, Xue L, Li L, Yang LL, Xu C, Dai J, Wang F, Li Q, Dong QX, Yang RF, Wu JR, Sun B. Severe acute respiratory syndrome coronavirus accessory protein 9b is a virion-associated protein. Virology. 2009 Jun 05; 388(2):279-85. PMID: 19394665.
      Citations: 29     Fields:    Translation:AnimalsCells
    10. Dong WQ, Bai B, Lin YP, Gao J, Yu NS. [Detection of the mRNA expression of human angiotensin-converting enzyme 2 as a SARS coronavirus functional receptor in human femoral head]. Nan Fang Yi Ke Da Xue Xue Bao. 2008 Mar; 28(3):441-3. PMID: 18359708.
      Citations: 1     Fields:    Translation:HumansCells
    11. Du L, Zhao G, Lin Y, Chan C, He Y, Jiang S, Wu C, Jin DY, Yuen KY, Zhou Y, Zheng BJ. Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection. Vaccine. 2008 Mar 20; 26(13):1644-51. PMID: 18289745.
      Citations: 46     Fields:    Translation:AnimalsCells
    12. Du L, Zhao G, Lin Y, Sui H, Chan C, Ma S, He Y, Jiang S, Wu C, Yuen KY, Jin DY, Zhou Y, Zheng BJ. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection. J Immunol. 2008 Jan 15; 180(2):948-56. PMID: 18178835.
      Citations: 67     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    13. Yang N, Tanner JA, Zheng BJ, Watt RM, He ML, Lu LY, Jiang JQ, Shum KT, Lin YP, Wong KL, Lin MC, Kung HF, Sun H, Huang JD. Bismuth complexes inhibit the SARS coronavirus. Angew Chem Int Ed Engl. 2007; 46(34):6464-8. PMID: 17645269.
      Citations: 27     Fields:    Translation:HumansCells
    14. Tanner JA, Zheng BJ, Zhou J, Watt RM, Jiang JQ, Wong KL, Lin YP, Lu LY, He ML, Kung HF, Kesel AJ, Huang JD. The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus. Chem Biol. 2005 Mar; 12(3):303-11. PMID: 15797214.
      Citations: 68     Fields:    Translation:AnimalsCells